Evolent Health (EVH) Gross Margin (2015 - 2026)

Evolent Health's Gross Margin history runs 12 years deep, the most recent figure standing at 16.88% for Q1 2026.

• On a quarterly basis, Gross Margin fell 431.0% year-over-year to 16.88% in Q1 2026; TTM through Mar 2026 was 20.18%, a 493.0% increase from a year earlier, with the FY2025 full-year figure at 21.31%, up 693.0% from the prior year.
• Gross Margin slipped to 16.88% in Q1 2026 per EVH's latest filing, from 20.75% in the prior quarter.
• Across five years, Gross Margin topped out at 27.41% in Q1 2023 and bottomed at 11.71% in Q4 2024.
• The 5-year median for Gross Margin is 21.19% (2025), against an average of 20.52%.
• Across the five-year window, Gross Margin slumped 1205 bps in 2022 and jumped 904 bps in 2025, its largest moves.
• Year by year, Gross Margin stood at 21.72% in 2022, then slipped by 16 bps to 18.28% in 2023, then plunged by 36 bps to 11.71% in 2024, then soared by 77 bps to 20.75% in 2025, then retreated by 19 bps to 16.88% in 2026.
• Per Business Quant, the three latest EVH Gross Margin figures stand at 16.88% (Q1 2026), 20.75% (Q4 2025), and 20.81% (Q3 2025).